Joel Crouzet, PhD, co-founder of InnaVirVax, with 20 years of experience in R&D, was Director of Research at Neurotech and AP Cells, and Departmental Director at Rhône-Poulenc Rorer (Sanofi Aventis). He invented two patents that are now in industrial use. He gained experience in business development as General Manager at Inserm-Transfert, and has received awards from Rhône-Poulenc, the French Academy of Sciences and the French Senate.

Shahin Gharakhanian MD, DTM&H, Dip.PH specializes in HIV medicine and infectious diseases. Until recently, he was Vice-President of Vertex Pharmaceuticals Inc., Medicines Development Group, Global R&D. During his career, his jobs have ranged from the General Manager of a full-service Contract Research Organization to Program Executive leading product development, regulatory approval/launch, and has thus gain extensive expertise in these areas.

Nathalie holds an MBA and has a PhD in endocrinology. She has gained experience if start-up development while working for several yeaNathalie Baran holds an MBA and a PhD in endocrinology. She gained experience of start-up development while working for several years at OSEO, the French Innovation Agency, and Genopole Entreprises, a Paris-region incubator. Her expertise lies in finance, grant raising and business development.

Raphaël Ho Tsong Fang, DVM & PhD in microbiology and medical virology, has worked for eight years on SIV (Simian ImmunoDeficiency Virus) and HIV infections at the Pasteur Institute in Paris and at UCLA, Los Angeles where he gained considerable knowledge of HIV disease and pathogenesis. He also has expertise in the non-clinical assessment of vaccines. He has actively participated to the development of VAC-3S at InnaVirVax.

Dominique Batéjat, Ms has expertise in biochemistry, molecular biology and pharmaceutical development. Her industrial experience includes working for Cellectis and Nautilus Biotech.